BAxSIC

• Research type

  Research Study

• Full title

  British Axial Spondyloarthritis Inception Cohort

• IRAS ID

  310374

• Contact name

  Helena Marzo-Ortega

• Contact email

  h.marzo-ortega@leeds.ac.uk

• Sponsor organisation

  Leeds Teaching Hospital NHS Trust

• Duration of Study in the UK

  3 years, 0 months, 1 days

• Research summary

  The British Axial Spondyloarthritis Cohort (BAxSIC) study has been established under the auspices of the British Society for Spondyloarthritis (BRITSpA) in collaboration with the National Axial Spondyloarthritis Society (NASS) to provide real-world data to evaluate the impact of delay in diagnosis (from symptom onset to diagnosis) on work participation and functional outcomes and the natural history and impact of newly-diagnosed axial Spondyloarthritis, including disease activity, pain, fatigue, functional and work outcomes, comorbidities, therapies in the UK.
  The study is a prospective cohort enrolling patients attending rheumatology clinics in the UK who are newly diagnosed with axial Spondyloarthritis and naïve to biologic therapy.
  The study will run for an initial 3 year period commencing December 2022.

• REC name

  Wales REC 7

• REC reference

  22/WA/0311

• Date of REC Opinion

  1 Nov 2022

• REC opinion

  Favourable Opinion